Goldman Sachs Identifies Two Biotech IPOs With Over 75% Upside Potential
Goldman Sachs analyst Salveen Richter initiates coverage on Latigo Biotherapeutics and Braveheart Bio, citing significant clinical potential and large addressable markets for…
Goldman Sachs analyst Salveen Richter initiates coverage on Latigo Biotherapeutics and Braveheart Bio, citing significant clinical potential and large addressable markets for…
Memory stocks surge as Goldman Sachs highlights technical breakouts and light positioning, though Kioxia warns that aggressive NAND price hikes could threaten…
Anthropic is finalizing a $15bn revolving credit facility led by Morgan Stanley, with Goldman Sachs, JPMorgan and Citigroup also taking senior roles,…
Smart ring maker Oura filed for a US IPO on Nasdaq under ticker OURA, targeting a $16 billion valuation as nine-month revenue…
Best CD rates today still reach 4.35% APY on an 18-month CD from Marcus by Goldman Sachs, with the Fed holding rates…
Goldman Sachs reiterates Buy ratings on Devon Energy (DVN) and HF Sinclair (DINO), citing dividend yields, free-cash-flow returns and valuation gaps despite…
Hashkey has joined the DTCC's tokenization innovation working group as the first Asian crypto service provider, placing it alongside over 100 financial…
XRP ETFs see $170M inflows over 11 days with Goldman Sachs as top institutional holder, signaling rising institutional demand for the cryptocurrency.
21 G7 banks including Goldman Sachs, Citi and BofA plan a dollar stablecoin followed by a euro offering, pressuring Tether and USDC…
Citi, Goldman Sachs and other global banks launch a stablecoin venture for dollar and euro digital payments, expanding institutional crypto adoption.
Goldman Sachs reports Hormuz oil flows at two-thirds of prewar levels, signaling tighter Gulf crude supply and bullish pressure on Brent and…
Uzbekistan's central bank turns to Goldman Sachs and BlackRock for reserve-management input, a move that could deepen ties between Wall Street and…